Log in

NYSE:GENGenesis Healthcare Competitors & Alternatives

$0.90
+0.01 (+1.12 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.89
Now: $0.90
$0.93
50-Day Range
$0.59
MA: $0.82
$1.16
52-Week Range
$0.58
Now: $0.90
$1.86
Volume934,249 shs
Average Volume582,421 shs
Market Capitalization$148.92 million
P/E Ratio2.44
Dividend YieldN/A
Beta1.31

Competitors

Genesis Healthcare (NYSE:GEN) Competitors and Alternatives

The following companies in the "medical" sector are considered alternatives and competitors to Genesis Healthcare.

Competitor NameBeat the Market RankCurrent PricePrice ChangeMarket CapRevenueP/E RatioIndicator(s)
CSTL
Castle Biosciences
1.4$37.69+0.5%$625.95 million$51.87 million-43.83Insider Selling
Atara Biotherapeutics logo
ATRA
Atara Biotherapeutics
1.3$9.74+0.8%$623.12 millionN/A-1.78Analyst Downgrade
Heavy News Reporting
Ardelyx logo
ARDX
Ardelyx
1.6$6.92+0.1%$622.06 million$5.28 million-5.28Analyst Downgrade
Insider Selling
DBV TECHNOLOGIE/S logo
DBVT
DBV TECHNOLOGIE/S
1.7$5.17+1.0%$621.75 million$14.75 million-2.22Heavy News Reporting
BLU
Bellus Health
1.2$10.34+0.3%$612.92 millionN/A0.00Analyst Upgrade
Syndax Pharmaceuticals logo
SNDX
Syndax Pharmaceuticals
1.6$16.89+0.7%$605.76 million$1.52 million-8.98
YI
111
0.6$7.00+1.9%$598.22 million$567.68 million-7.78Heavy News Reporting
Dynavax Technologies logo
DVAX
Dynavax Technologies
2.1$6.09+6.4%$597.33 million$35.22 million-3.31Analyst Upgrade
Trillium Therapeutics logo
TRIL
Trillium Therapeutics
1.6$7.15+2.8%$596.60 million$120,000.00-3.56Heavy News Reporting
GenMark Diagnostics logo
GNMK
GenMark Diagnostics
1.6$9.14+5.0%$594.45 million$88.02 million-12.69
Quotient logo
QTNT
Quotient
1.0$6.56+6.3%$590.29 million$29.13 million-4.23Upcoming Earnings
PRVL
Prevail Therapeutics
1.5$16.62+3.4%$587.93 millionN/A-7.26Heavy News Reporting
Radius Health logo
RDUS
Radius Health
1.9$12.25+2.7%$583.57 million$173.32 million-4.42Analyst Downgrade
Pacific Biosciences of California logo
PACB
Pacific Biosciences of California
1.5$4.03+6.7%$577.76 million$90.89 million-11.85
VAPO
Vapotherm
0.9$30.23+4.1%$576.79 million$48.10 million-11.32Analyst Report
Heavy News Reporting
FREQ
Frequency Therapeutics
1.5$18.82+1.9%$572.50 million$28.95 million-8.22Insider Selling
Tivity Health logo
TVTY
Tivity Health
2.1$11.38+5.0%$565.64 million$1.13 billion-1.13
Lantheus logo
LNTH
Lantheus
0.8$14.61+0.5%$564.94 million$347.34 million23.56
APRE
Aprea Therapeutics
1.3$26.94+1.4%$559.22 millionN/A-5.77
Athersys logo
ATHX
Athersys
1.4$2.78+1.8%$556.04 million$5.63 million-9.27
Urogen Pharma logo
URGN
Urogen Pharma
1.6$26.58+1.5%$555.52 million$20,000.00-4.59
Zafgen logo
ZFGN
Zafgen
0.9$14.70+8.8%$550.81 millionN/A-15.31
Precigen logo
PGEN
Precigen
2.2$3.21+0.6%$547.82 million$90.72 million-1.57Unusual Options Activity
Heavy News Reporting
SurModics logo
SRDX
SurModics
1.4$42.24+4.0%$539.88 million$100.08 million86.20
LeMaitre Vascular logo
LMAT
LeMaitre Vascular
2.3$28.22+4.5%$538.97 million$117.23 million32.44
MeiraGTx logo
MGTX
MeiraGTx
1.5$14.35+0.3%$537.61 million$13.29 million-9.70Analyst Downgrade
Heavy News Reporting
AnaptysBio logo
ANAB
AnaptysBio
1.2$18.67+2.0%$536.87 million$8 million-6.04
Aptose Biosciences logo
APTO
Aptose Biosciences
2.0$7.07+1.3%$534.68 millionN/A-13.34Heavy News Reporting
Crinetics Pharmaceuticals logo
CRNX
Crinetics Pharmaceuticals
1.4$15.99+3.3%$526.91 million$1.19 million-6.61Analyst Downgrade
Rubius Therapeutics logo
RUBY
Rubius Therapeutics
2.2$6.37+1.6%$520.68 millionN/A-2.83Analyst Upgrade
Autolus Therapeutics logo
AUTL
Autolus Therapeutics
1.4$13.14+0.7%$518.28 million$2.91 million-4.71Analyst Report
BCEL
Atreca
1.6$18.34+0.5%$517.12 millionN/A-3.22Analyst Downgrade
Insider Selling
SIBN
SI-Bone
1.7$17.81+2.0%$516.52 million$67.30 million-10.86Insider Selling
Viking Therapeutics logo
VKTX
Viking Therapeutics
1.8$7.38+3.4%$516.16 millionN/A-17.57Analyst Report
Heavy News Reporting
CVM
Cel-Sci
0.6$13.69+1.3%$515.21 millionN/A0.00Analyst Upgrade
Anika Therapeutics logo
ANIK
Anika Therapeutics
1.9$36.96+6.0%$511.20 million$114.51 million20.20
Corbus Pharmaceuticals logo
CRBP
Corbus Pharmaceuticals
2.2$6.89+0.0%$508.30 million$36.14 million-6.10Analyst Downgrade
Unusual Options Activity
Heavy News Reporting
Antares Pharma logo
ATRS
Antares Pharma
1.9$3.12+6.4%$504.96 million$123.86 million156.08
Clovis Oncology logo
CLVS
Clovis Oncology
1.7$6.68+3.0%$498.31 million$143.01 million-0.93
Owens & Minor logo
OMI
Owens & Minor
2.6$7.89+1.1%$491.48 million$9.21 billion-7.89
Scholar Rock logo
SRRK
Scholar Rock
1.6$16.99+7.0%$486.05 million$20.49 million-8.50Analyst Downgrade
Heavy News Reporting
Establishment Labs logo
ESTA
Establishment Labs
2.1$20.64+6.1%$484.31 million$89.57 million-9.74
Triple-S Management logo
GTS
Triple-S Management
2.2$19.66+3.5%$484.21 million$3.38 billion14.46
BioDelivery Sciences International logo
BDSI
BioDelivery Sciences International
1.9$4.81+1.5%$482.52 million$111.39 million-53.44
DURECT logo
DRRX
DURECT
1.6$2.41+5.8%$480.26 million$29.56 million-20.08Insider Selling
Beyondspring logo
BYSI
Beyondspring
1.3$17.29+1.5%$474.89 millionN/A-11.30
NLTX
Neoleukin Therapeutics
1.8$12.20+0.1%$468.11 million$25 million-4.57
FULC
Fulcrum Therapeutics
1.4$19.04+5.5%$466.53 millionN/A-1.63
VBI Vaccines logo
VBIV
VBI Vaccines
2.1$2.00+5.0%$465.91 million$2.22 million-5.71
Flexion Therapeutics logo
FLXN
Flexion Therapeutics
2.4$12.30+3.4%$463.11 million$72.96 million-3.25Analyst Report
This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.